Josef Priller

Prof Josef Priller

Group Leader

Defining and modulating myeloid cell function in neurodegenerative diseases

Biography

Prof Josef Priller is Chair of Brain Inflammation at the University of Edinburgh and Repair and Professor of Neuropsychiatry at Charité University Berlin. After studying medicine at the Max-Planck-Institute of Medicine and Psychiatry, he went on to specialise in neurology and psychiatry, with a particular interest in inflammation, bridging clinical work and basic research in the lab. As a UK DRI Group Leader, he leads a novel research programme at the UK DRI at Edinburgh using stem cells to investigate microglia in neurodegenerative diseases.

News

Key publications

Journal of Alzheimer's disease : JAD
Published
A computational ontology framework for the synthesis of multi-level pathology reports from brain MRI scans
Authors
Devesh Singh, Alice Grazia, Achim Reiz, Andreas Hermann, Slawek Altenstein, Lukas Beichert, Alexander Bernhardt, Katharina Buerger, Michaela Butryn, Peter Dechent, Emrah Duezel, Michael Ewers, Klaus Fliessbach, Silka D Freiesleben, Wenzel Glanz, Stefan Hetzer, Daniel Janowitz, Ingo Kilimann, Okka Kimmich, Christoph Laske, Johannes Levin, Andrea Lohse, Falk Luesebrink, Matthias Munk, Robert Perneczky, Oliver Peters, Lukas Preis, Josef Priller, Johannes Prudlo, Boris S Rauchmann, Ayda Rostamzadeh, Nina Roy-Kluth, Klaus Scheffler, Anja Schneider, Luisa S Schneider, Björn H Schott, Annika Spottke, Eike J Spruth, Matthis Synofzik, Jens Wiltfang, Frank Jessen, Stefan J Teipel, Martin Dyrba, ADNI, AIBL, FTLDNI, study groups
A computational ontology framework for the synthesis of multi-level pathology reports from brain MRI scans
Molecular psychiatry
Published
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
Authors
David Mengel, Ester Soter, Julia Maren Ott, Madeleine Wacker, Alejandra Leyva, Oliver Peters, Julian Hellmann-Regen, Luisa-Sophie Schneider, Xiao Wang, Josef Priller, Eike Spruth, Slawek Altenstein, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Niels Hansen, Ayda Rostamzadeh, Emra Düzel, Wenzel Glanz, Enise I Incesoy, Katharina Buerger, Daniel Janowitz, Michael Ewers, Robert Perneczky, Boris Rauchmann, Stefan Teipel, Ingo Kilimann, Christoph Laske, Sebastian Sodenkamp, Annika Spottke, Johanna Brustkern, Frederic Brosseron, Michael Wagner, Melina Stark, Luca Kleineidam, Kai Shao, Falk Lüsebrink, Renat Yakupov, Matthias Schmid, Stefan Hetzer, Peter Dechent, Klaus Scheffler, David Berron, Frank Jessen, Matthis Synofzik, DELCODE study group
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease

Priller Lab

Explore the work of the Priller Lab, developing cutting-edge techniques to help advance research into the role of microglia in neurodegenerative diseases

Priller Lab
A slice of brain tissue stained with a blue marker